THE CALANDRA REPORT: Subscribe $91 yearly SAN DIEGO — Inovio Pharmaceuticals (INO in USA), a DNA vaccine developer I sidestepped for four years, is having success with a Middle Eastern virus. INO shares are raging today. Inovio’s J, Joseph Kim, via a persistent biz-dev executive, Bernie Hertel, has been on me, professionally, since 2009. Inovio… Continue Reading
Eight well known gold stocks slide to 52 week lows
A life changing addition to your morning routine
5 Things That You Might See Near a Market Top
Are You Having Enough High Stakes Moments?
The Lundins make another timely acquisition, this time with NGEx
Africa Oil trading at 52-week low on misunderstood news